| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |